Simple water‐based tacrolimus enemas for refractory proctitis

Infliximab for refractory ulcerative proctitis.

BACKGROUND Efficacy of infliximab in treating ulcerative proctitis remains unknown. AIM To evaluate the clinical, biological and endoscopic efficacy of infliximab therapy in refractory proctitis. METHODS The charts of 420 patients treated with infliximab for ulcerative colitis were reviewed. Thirteen patients were treated with infliximab for refractory ulcerative proctitis in six referral c...

Tacrolimus for Refractory Nephrotic Syndrome

Refractory Ulcerative Proctitis—A Brief Review

Ulcerative proctitis (UP) is a common condition in adult patients and can be very difficult to treat. This review considers critically the definition of this entity, its epidemiology and course, and the modes of therapy currently available. Therapies currently in development are considered as well.

Tacrolimus for rescue of refractory renal allograft rejection.

SIGNIFICANT improvements in the results of renal transplantation in the 1980s were largely due to the development of cyclosporine (CyA) and the use of antilymphocyte agents for induction protocols and/or treatment of rejection. However, rejection refractory to treatment with corticosteroids and/or antilymphocyte agents has remained a major obstacle to long-term success and account for a signifi...

Successful treatment of refractory Takayasu arteritis with tacrolimus.